Jeffrey Danzig, MD
Gastroenterology · Ridgewood, NJNPI 1689653909
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,725 of the $47,637 with a category attached, or 87.6%. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 94.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $27,095 and has fallen 97.0% since, to $812 in 2025. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $169.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45K
- Bristol Myers Squibb$416
- Takeda Pharmaceuticals U.S.A., Inc.$400
- AbbVie$365
- Johnson & Johnson$313
- Merck$203
- plus $909 from 13 others
What the payments were for
- Speaking & faculty fees$41,72588%
- Travel & lodging$1,8664%
- Food & beverage$4,0468%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 73 | $45,032 |
| Bristol Myers Squibb | 49 | $416 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $400 |
| AbbVie | 36 | $365 |
| Johnson & Johnson | 21 | $313 |
| Merck | 12 | $203 |
| Lilly USA, LLC | 10 | $175 |
| Pfizer | 12 | $174 |
| Ferring Pharmaceuticals Inc. | 12 | $170 |
| Sanofi | 5 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $69 |
| Madrigal Pharmaceuticals | 4 | $58 |
| Intercept Pharmaceuticals, Inc. | 2 | $41 |
| Ardelyx, Inc. | 2 | $35 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Celltrion USA Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Gilead | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,637 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 69 | $65,120 |
| MotegrityPrucalopride Succinate | 36 | $30,727 |
| TrulancePlecanatide | 18 | $20,788 |
| ZenpepLipase/Protease/Amylase | 21 | $10,964 |
| Esomeprazole Magnesium | 177 | $10,844 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 43 | $7,417 |
| Dexlansoprazole DrDexlansoprazole | 13 | $5,916 |
| Dicyclomine Hcl | 176 | $4,651 |
| Pantoprazole Sodium | 238 | $4,209 |
| Misoprostol | 49 | $3,342 |
| Colchicine | 26 | $2,862 |
| Colestipol Hcl | 30 | $2,520 |
| Lubiprostone | 21 | $2,425 |
| Famotidine | 130 | $2,045 |
| Rabeprazole Sodium | 58 | $1,981 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $365 | $65,12069 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $400 | $30,72736 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $45,032 | $20,78818 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $170 | $7,41743 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Ridgewood
- Haleh PazwashRidgewood$126K
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.